We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

NIH Clinical Trial Begins for Treatment of Rare, Fatal Neurological Disorder

News   Apr 29, 2013

 
NIH Clinical Trial Begins for Treatment of Rare, Fatal Neurological Disorder
 
 
 

RELATED ARTICLES

Post-heart Attack Antibody Levels May Guide Treatment

News

Levels of antiphospholipid antibodies, which are associated with rheumatic diseases, are also elevated in myocardial infarction without any autoimmune co-morbidity.

READ MORE

Drug Combo Destroys Chemo-resistant Blood Cancer

News

Researchers have developed a promising targeted strategy to treat chemotherapy-resistant acute myeloid leukemia (AML) and a diagnostic test to determine which AML patients would most likely benefit from this treatment.

READ MORE

Aspirin Stops Clots After Knee Surgery

News

Putting patients on aspirin following a knee replacement is a safe, cost-effective alternative to anticoagulants, U-M researchers find.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE